Expertise in
9
conditions

Xueqing C. Yu

No. 19 Renmin Road, 
Zhengzhou, CN 
Expertise in
9
conditions
No. 19 Renmin Road, 
Zhengzhou, CN 

Overview

Xueqing Yu practices practicing medicine in Zhengzhou, China.

Yu is highly rated in 9 conditions, according to our data. Their clinical expertise encompasses IgA Nephropathy, Chronic Kidney Disease, Glomerulonephritis, Secondary Peritonitis, and Kidney Transplant.

They are actively involved in clinical research, co-authoring 288 peer reviewed articles and participating in 2 clinical trials.

Locations

No. 19 Renmin Road, Zhengzhou, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 1b, Multicenter, Open-Label Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Mezagitamab (TAK-079) in Patients With Primary IgA Nephropathy in Combination With Stable Background Therapy
A Phase 1b, Multicenter, Open-Label Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Mezagitamab (TAK-079) in Patients With Primary IgA Nephropathy in Combination With Stable Background Therapy
Enrollment Status: Completed
Publish Date: June 01, 2026
Intervention Type: Drug
Study Drug: Mezagitamab
Study Phase: Phase 1
Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study Low Dose Study
Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study Low Dose Study
Enrollment Status: Completed
Publish Date: September 23, 2021
Intervention Type: Drug
Study Phase: Not Applicable
View 1 Less Clinical Trial

288 Total Publications

Safety, Pharmacokinetics, and Pharmacodynamics of SHR6508, a Calcium-Sensing Receptor Agonist, in Maintenance Hemodialysis Patients With Secondary Hyperparathyroidism: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.
Safety, Pharmacokinetics, and Pharmacodynamics of SHR6508, a Calcium-Sensing Receptor Agonist, in Maintenance Hemodialysis Patients With Secondary Hyperparathyroidism: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.
Journal: Kidney medicine
Published: July 01, 2026

Frequently Asked Questions about Xueqing C. Yu

Is Xueqing C. Yu a top-rated expert for IgA Nephropathy?

MediFind is an objective health platform that identifies experts based on real-world data. Xueqing C. Yu is classified as an Distinguished expert for IgA Nephropathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Xueqing C. Yu participate in research or clinical trials?

Yes. Xueqing C. Yu has published 288 articles and abstracts on conditions like IgA Nephropathy. You can view a list of Xueqing C. Yu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yu's expertise for a condition
ConditionClose
    View All 29 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile